White Matter Disease Neurology Rotation Lecture Series Last Updated by Lindsay Pagano Summer 2013.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Multiple Sclerosis (MS) LaTasha Wilson Nate Jr.. Pathophysiology of MS In MS, the body’s own defense system attacks myelin, the fatty substance that surrounds.
DEMYELINATING DISEASES (MULTIPLE SCLEROSIS)
Z.Vaseie MD Emergency Medicine Resident Guillain Barre Syndrom (GBS)  Group of autoimmune conditions involving demyelination and acute axonal degeneration.
Spinal Cord Dysfunction
Neurology Chapter of IAP Guillain-Barre’. Neurology Chapter of IAP Guillain-Barre’ Syndrome Post-infectious polyneuropathy; ascending polyneuropathic.
Acute Peripheral Weakness Peter Shearer, MD Assistant Residency Director Mt. Sinai School of Medicine.
Devic’s neuromyelitis optica: its distinctive features and treatment
Overview of Multiple Sclerosis  Valerie Robinson, D.O. 
Practical Management of MS in the Primary Care Office Setting Case Study 2.
Degenerative Myelopathy Copyright University of Florida 1998 Of German Shepherd Dogs A chronic, progressive neurodegenerative disease Initial signs are.
Guillain-Barre Syndrome
What is MS? Multiple Sclerosis (MS) is an inflammatory disease of the Central Nervous System (CNS) - that's the brain and spinal cord. Predominantly,
Acute Seizure Management Neurology Rotation Lecture Series Last Updated by Lindsay Pagano Summer 2013.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Multiple Sclerosis (MS) By: Morgan Farr Biology 1010.
Multiple Sclerosis BY: SARAH BURGESS. “For every male that is diagnosed with multiple sclerosis there is three women diagnosed”
“I Think My 17 Month Old Baby’s Drunk” Daniel P. Davis, MD UCSD Emergency Medicine.
Pediatric Neurology Use of Biologic and Chemotherapeutic Agents Pediatric Neurology Use of Biologic and Chemotherapeutic Agents.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
MedPix Medical Image Database COW - Case of the Week Case Contributor: Steven J Goldstein Affiliation: University of Kentucky.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
Aseptic meningitis  definition: When the CSF culture was negative.  CSF: pressure mmh2o: normal or slightly elevated. leukocytes : PMN early mononuclear.
Guillain-Barré Syndrome Miss Fatima Hirzallah Guillain-Barré syndrome is an autoimmune attack on the peripheral nerve myelin. The result is acute, rapid.
Multiple Sclerosis Brett Catlin Period Seven September 3 rd, 2003.
Acute inflammatory demyelinating polyradiculoneuropathy (AIDP)
Guillain Barre Syndrome
Guillain-Barré syndrome (GBS)
SPINAL NERVE ROOT COMPRESSION AND PERIPHERAL NERVE DISORDERS Group A – AHD Dr. Gary Greenberg.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Multiple Sclerosis Alan Chen 4/1/14. General Information Other names: disseminated sclerosis or encephalomyelitis disseminata Inflammatory disease that.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Multiple Sclerosis A chronic, progressive central nervous system disease with a disseminating demyelination of the nerve fibers of the brain and spinal.
Practical Management of MS in the Primary Care Office Setting Case Study 1.
Int J MS Care 7: , 2005/2006. Jan 9 & 10, Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department.
HERPES SIMPLEX ENCEPHALITIS ENCEPHALITIS M.RASOOLINEJAD, MD DEPARTMENT OF INFECTIOUS DISEASE TEHRAN UNIVERCITY OF MEDICAL SCIENCE.
Guillain-Barre’ Syndrome
Updates on Optic Neuritis Briar Sexton Neuro-ophthalmology Clinical Day Friday, November 18, 2005.
MULTIPLE SCLEROSIS Ana Costas Barreiro.
MS مولتیپل اسکلروزیس. Client with Multiple Sclerosis Description Chronic demyelinating disease of CNS associated with - abnormal immune response to environmental.
Nathan McNeil, MD 4/15/2010.  1859, Landry published a report on 10 patients with an ascending paralysis  Subsequently, in 1916, 3 French physicians.
Group A – AHD Dr. Gary Greenberg
Department of Neurology, The 2nd affiliated hospital, kunming Medical College Yinfengqiong.
EXEMPLAR OF MULTIPLE SCLEROSIS INTRODUCTION AND ASSESSMENT.
Peripheral Neuropathy Clinical Management Course February 12, 2007
A 13 years old girl with Acute Flaccid Paralysis F.Ahmadabadi Child Neurologist.
Clinico-Radiological Profile of Spinal Cord Multiple Sclerosis Glenn H. Roberson Bhavik N. Patel Asim K. Bag University of Alabama at Birmingham, Birmingham,
Case Report Our patient is a 16 y/o Latin American girl referred from an outside hospital for symptoms of left flank pain radiating to the left lower leg.
Magnetic Resonance Imaging In Young Patients With Neuro - Psychiatric SLE : A Case Series Dr. Vivek Gupta Department of Radiodiagnosis Postgraduate Institute.
Multiple Sclerosis. What is MS? This is a chronic and often disabling disease in which the body’s immune system (t-cells) attacks the central nervous.
陳京瑜.  Inflammatory  Infectious  Hereditary  Acquired metabolic and toxic  Traumatic  Tumor.
 Post-infectious polyneuropathy; ascending polyneuropathic paralysis  An acute, rapidly progressing and potentially fatal form of polyneuritis.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
POSTER TITLE: CLINICAL AND RADIOLOGICAL PROFILE, TREATMENT AND OUTCOME OF PEDIATRIC ACQUIRED DEMYELINATING DISORDERS OF CENTRAL NERVOUS SYSTEM PRESENTER.
Guillain-Barre Syndrome
ACUTE FLACCID PARALYSIS Dr Shreedhar Paudel May, 2009
ACUTE FLACCID PARALYSIS
AMYOTROPHIC LATERAL SCLEROSIS
Dr. Kevin J. Pacheco Weakness.
Guillain-Barre´ Syndrome
Multiple Sclerosis.
Neuro-ophthalmology.
CNS DEMYELINATING DISEASES (MULTIPLE SCLEROSIS)
Morning Report 3/15/18 Kathryn Rimmer
Figure 1 Percent positivity by clinical feature Overall, 6
A Curious Case of NMO Transverse Myelitis – Mystery Solved. Anna M
Figure 1 Full-length MOG cell-based assay using a serum dilution of 1:160 as a cutoff for positivity (red line in both plots)(A) Myelin olidgodendrocyte.
PEREHHRAL NERVOUS SYSTEM
Presentation transcript:

White Matter Disease Neurology Rotation Lecture Series Last Updated by Lindsay Pagano Summer 2013

Case Presentation The ED calls you in consultation for a 10 year old female with fever, altered mental status and weakness. Normal state of health until 7 days ago when she developed cough and fever In the last 2 days, started acting irritable and then sleepy Over the last 24 hours, has developed right sided weakness General exam: crackles on lung exam Neuro exam: pertinent positives –MS: sleepy but arousable with slightly painful stimulation –Motor: right UE and LE with 1-2/5 strength diffusely, hypotonia –Reflexes: brisk on the right –Sensory: responds to painful stimulation in all 4 extremities Differential?

ADEM Acute disseminated encephalomyelitis Presents with –Altered mental status/encephalopathy (irritability to obtunded) –Acute/subacute onset of focal symptoms based on lesions (max neuro symptoms over 4-7 days) –Typically still during febrile illness (typically URI) –1/3 with seizures Workup –Labs: none are diagnostic –CSF: pleocytosis, elevated protein, elevated IgG index; rule out infection! –Imaging: MRIbrain with contrast Treatment: IV steroids (ok to start while r/o infection and prophylactic antibiotics are on board) > IVIg > PLEX; PT Outcome –Recovery over 4-6 weeks % with no residual defecits –Repeat MRI 6-12 months later to assess for lesion resolution

Guillain-Barré Syndrome Aka AIDP, acute inflammatory demyelinating polyneuropathy History: febrile illness 2-4 weeks prior to onset pain, paresthesias and ascending weakness Pathophysiology –grouping of acute immune mediated polyneuropathies (cross reacting Ab to GM1 ganglioside) – both humoral factors and cell-mediated immune phenomena that damage myelin and/or the myelin-producing Schwann cells –2/3 with antecedent respiratory or diarrheal illness 2-4 weeks prior; c. jejuni most frequent (30%) Neuro Exam: distal > proximal weakness, hypotonia and areflexia; sensation testing may be intact despite subjective feelings of numbness and paresthesias Be wary of potential autonomic involvement! Monitor on tele, q4h nifs, continuous pulse ox Workup –Labs: None –LP: albuminocytologic dissociation –EMG/NCV: demyelination (  slowed nerve conduction velocities) –MRI: not indicated for diagnosis (MRIspine would show nerve root enhancement) Treatment: IVIg > PLEX + PT –Treatment doesn’t change overall outcome/degree of recovery Recovery over weeks-couple months; initial severity doesn’t correlate with length of course

Transverse Myelitis Focal inflammatory disease process of the spinal cord –Affects motor, sensory and autonomic fibers –Up to 50% with preceding febrile illness Highest incidence between yo, yo (bimodal) Present with –Acute/subacute onset of pain, weakness, sensory loss, incontinence over hours-weeks –80% of cases are in the thoracic spine Neuro exam: depends on where the lesion is! –Typically bilateral weakness with UMN signs, but… –If anterior horn cells are involved, may get a predominantly LMN exam Workup: –Labs: none positive for this condition, but can get labs to rule out other disease processes –CSF: pleocytosis, elevated IgG index –Imaging: MRIspine, with and without contrast Treatment: IV steroids + PT Outcome: 1/3 no long term sequelae, 1/3 mild-moderate disability, 1/3 severe disability

Multiple Sclerosis Chronic demyelinating disease 5% patients present before age 18 –95% of these have a relapsing remitting course: little to no disability inbetween flares (versus primary progressive, secondary progressive, progressive relapsing) MacDonald Criteria for diagnosis: lesions separated by space and time –Check the FLAIR and post contrast to help date lesions in 1 st presentation Presentation/Neuro exam: dependent on location of lesions –No prodromal illness –Not all lesions are symptomatic Workup –Labs: none diagnostic –CSF: pleocytosis, increased protein, elevated IgG index/oligoclonal bands present –Imaging: MRIbrain with contrast Periventricular lesions Dawson’s fingers –Visual evoked potentials (slowed conduction if optic nerves affected) Treatment –Acute: MS trial: IV methyprednisolone + steroid taper –Long term: interferon, glatiramir

Neuromyelitis Optica Aka NMO, Devic Disease Diagnostic Criteria 1. Optic neuritis AND 2. Transverse myelitis AND 3. -MRI evidence of myelitis incolving 3 or more contiguous segments OR -NMO-IgG + (aquaporin 4, found in serum) The above do not have to occur simultaneously May also have CNS lesions and resulting symptoms Clinical course is primary progressive or relapsing-remitting Worse recovery of vision [from optic neuritis] and strength [from myelopathy] as compared to MS 93% with recurrent attacks, 90% with residual disability

PREP question A 12 year old girl presents with a 2 day history of progressive back pain and difficulty walking, especially up stairs. This morning she had trouble dressing and combing her hair. On PE, the girls vital signs and stable and she is not short of breath. Cardiac, pulmonary, and joint evaluation results are normal. Neurologic exam reveals normal mental status and cranial nerves. Strength is diffusely reduced in the arms and legs, and reflexes are absent. Her gait is slow, and she requires assistance Ato arise from the floor. Noncontrast head CT scan results are normal. Forced vital capacity is normal. LP reveals a CSF protein of 100 mg/dL. CSF WBC count, RBC count and glucose are normal. You admit the girl for cardiorespiratory monitoring and treatment. Of the following, the treatment that is MOST likely to be beneficial in hastening this child’s recovery is: A.Immune globulin intravenously B.Methotrexate intrathecally C.Methylprednisolone intravenously D.Neostigmine intravenously E.Tissue plasminogen activator intravenously

A. IVIg GBS (Guillain-Barre syndrome) aka AIDP (acute inflammatory demyelinating polyneuropathy) –Localize! –Albuminocytologic dissociation –IVIg 2g/kg divided over 3 vs 5 days (may pretx) –Need to monitor respiratory (NIFs, FVCs) and cardiovascular (tele) status, ICU if needed Regarding the other choices: B. Methotrexate IV: chemotherapy used for CNS malignancy C. Methyprednisolone IV: not effective as monotherapy D. Neostigmine IV: acetylcholinesterase inhibitor, for NMJ junction disease, eg myasthenia gravis E. tPA IV: given in adult acute stroke